ConductScience.org, home

Paper29686151

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.

Stader F and 6 others. Antimicrob Agents Chemother, 2018. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications. Papers, record 29686151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29686151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2019-09-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stader FFelix
2Kinvig HHannah
3Battegay MManuel
4Khoo SSaye
5Owen AAndrew
6Siccardi MMarco
7Marzolini CCatia

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Retroviral AgentsMajor topic
Cytochrome P-450 CYP3A InhibitorsMajor topic
HIV InfectionsMajor topic
Cytochrome P-450 CYP3A
Drug Interactions
Humans
Monte Carlo Method

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123568224Investigation of the effects of ketoconazole on the pharmacokinetics of macitentan, a novel dual endothelin receptor antagonist, in healthy subjects.Clin Pharmacokinet2013https://conductscience.org/library/papers/23568224PubMed
220380564Recognition of risk for clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy.Clin Infect Dis2010https://conductscience.org/library/papers/20380564PubMed
317896893Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy.Pharmacotherapy2007https://conductscience.org/library/papers/17896893PubMed
43802710Cimetidine and ranitidine increase midazolam bioavailability.Clin Pharmacol Ther1987https://conductscience.org/library/papers/3802710PubMed
58181191Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.Clin Pharmacol Ther1994https://conductscience.org/library/papers/8181191PubMed
68623953The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.Anesth Analg1996https://conductscience.org/library/papers/8623953PubMed
72933205Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam.Clin Pharmacol Ther1985https://conductscience.org/library/papers/2933205PubMed
816639344
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
J Acquir Immune Defic Syndr2006https://conductscience.org/library/papers/16639344PubMed
914551182Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.J Clin Pharmacol2003https://conductscience.org/library/papers/14551182PubMed
1016580903Comparison of midazolam and simvastatin as cytochrome P450 3A probes.Clin Pharmacol Ther2006https://conductscience.org/library/papers/16580903PubMed
1110320951Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.Clin Pharmacokinet1999https://conductscience.org/library/papers/10320951PubMed
1215980690Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study.J Acquir Immune Defic Syndr2005https://conductscience.org/library/papers/15980690PubMed
1325006781Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin.CPT Pharmacometrics Syst Pharmacol2014https://conductscience.org/library/papers/25006781PubMed
149542477Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.Clin Pharmacol Ther1998https://conductscience.org/library/papers/9542477PubMed
1510579473Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.Clin Pharmacol Ther1999https://conductscience.org/library/papers/10579473PubMed
1615784650CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactions.J Pharmacol Exp Ther2005https://conductscience.org/library/papers/15784650PubMed
179626922Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.Eur J Clin Pharmacol1998https://conductscience.org/library/papers/9626922PubMed
1820516560Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.Antivir Ther2010https://conductscience.org/library/papers/20516560PubMed
1927226953Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance.Curr Pharmacol Rep2016https://conductscience.org/library/papers/27226953PubMed
2016390352Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.Br J Clin Pharmacol2006https://conductscience.org/library/papers/16390352PubMed

See all 56 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42076117Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens.Pharmaceutics2026https://conductscience.org/library/papers/42076117PubMed
41308787Biowaiver monograph for immediate-release solid oral dosage forms: Amlodipine besylate.J Pharm Sci2026https://conductscience.org/library/papers/41308787PubMed
37496693Antiviral Treatment in Older Chinese Patient with SARS-CoV-2 and Influenza A Virus Co-Infection: A Case Series.Infect Drug Resist2023https://conductscience.org/library/papers/37496693PubMed
36253637Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series.J Thromb Thrombolysis2022https://conductscience.org/library/papers/36253637PubMed
33731842Potential drug-drug interactions of antiretrovirals and antimicrobials detected by three databases.Sci Rep2021https://conductscience.org/library/papers/33731842PubMed
33626178Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33626178PubMed
33452585Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.Eur J Clin Pharmacol2021https://conductscience.org/library/papers/33452585PubMed
32011104The challenge of HIV treatment in an era of polypharmacy.J Int AIDS Soc2020https://conductscience.org/library/papers/32011104PubMed
31583609Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.Clin Pharmacokinet2020https://conductscience.org/library/papers/31583609PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP3A4364816PubTator's text mininghttps://conductscience.org/library/genes/64816NCBI Gene
CYP3A51577PubTator's text mininghttps://conductscience.org/library/genes/1577NCBI Gene
CYP3A71551PubTator's text mininghttps://conductscience.org/library/genes/1551NCBI Gene
UGT1A454657PubTator's text mininghttps://conductscience.org/library/genes/54657NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29686151

GET https://conductscience.org/api/papers/v1/29686151/references?page=2